> Novartis ($NVS) has launched myelofibrosis drug Jakavi in Singapore and 50 other countries. Report
> Johnson & Johnson's ($JNJ) Janssen has won EU marketing authorization for hep C drug Olysio. Release
> Tolmar Pharma has regained marketing rights for prostate cancer drug Eligard in the U.S. and Puerto Rico. More
> A new report highlights the meningococcal vaccines market through 2019. Release
And Finally... Some tech companies are betting that sifting through patients' social media posts will yield critical side-effect insights that drugmakers will buy. More